Related Experiment Video
Updated: Apr 3, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Development and validation of a multifactorial risk prediction model for breast cancer patients with co-occurring
Junming Yin1, Zhiwei Guo2, Wen Yi1
1Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan, China.
Objective:
To develop and validate a multifactorial machine learning model predicting thyroid cancer (TC) co-occurrence risk in breast cancer (BC) patients.
Methods:
This single-center retrospective matched case-control study analyzed 400 BC patients (200 with co-occurring TC, 200 matched BC-only controls) diagnosed between 2012-2025. Predictors included demographic, clinical, hormonal, and tumor biological variables. After feature selection via LASSO regression to handle multicollinearity, four machine learning algorithms (logistic regression, random forest, XGBoost, SVM) were developed and optimized using Bayesian hyperparameter tuning with 5-fold cross-validation. Model performance was evaluated on a 30% independent test set using AUC-ROC, calibration curves, and decision curve analysis.
Results:
Multivariate analysis identified independent risk factors for TC co-occurrence: radiotherapy history (aOR = 3.42, 95% CI: 2.14-5.46), elevated TSH level (aOR = 2.01 per µIU/mL, 95% CI: 1.65-2.45), ER-positive status (aOR = 2.47, 95% CI: 1.43-4.28), family history of TC (aOR = 3.05, 95% CI: 1.55-6.00), and younger age at BC diagnosis (aOR = 1.07 per year decrease, 95% CI: 1.04-1.10). The XGBoost model demonstrated superior discrimination (test AUC = 0.874, 95% CI: 0.836-0.934) compared to other algorithms, with 86.7% accuracy, 83.3% sensitivity, and 90.0% specificity. Notably, subgroup analysis revealed enhanced predictive performance in patients with a history of radiotherapy (AUC = 0.921). Decision curve analysis confirmed clinical utility across threshold probabilities (20-80%), showing a superior net benefit for personalized risk stratification.
Conclusion:
The XGBoost-based model integrates radiotherapy exposure, hormonal profiles, and tumor biology to stratify TC risk in BC patients. It offers a clinically applicable tool for personalized surveillance, balancing early detection with resource optimization. External validation is warranted before implementation.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Cancer Survival Analysis
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study

